New drug duo tested in Tough-to-Treat stomach and liver cancers
NCT ID NCT04798781
Summary
This study tested whether combining two drugs, telatinib and Keytruda, could help control advanced stomach or liver cancers that had worsened after standard treatments. It involved 16 patients with these specific cancers. The main goal was to see how long the combination could keep the cancer from growing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CS Cancer Beverly Hills
Beverly Hills, California, 90211, United States
-
CS Cancer at The Angeles Clinic and Research Institute
Los Angeles, California, 90025, United States
-
CS Cancer at the Samuel Oschin Cancer Center
Los Angeles, California, 90048, United States
Conditions
Explore the condition pages connected to this study.